Imaging Retinal Vasculature in Infant Eyes

Status Not yet recruiting

Clinical Trial Summary

Retinopathy of prematurity is a leading cause of childhood blindness worldwide. The fovea, a critical location in the retina determining visual acuity and visual function, and the blood vessels around it, are abnormally developed in infants with retinopathy of prematurity. However, how these blood vessels form during development of the human fovea remains unclear. This research will advance our understanding of the fundamental knowledge of how the blood vessels around the fovea form in infants, and how they change in diseased states such as preterm birth or retinopathy of prematurity.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05558059
Study type	Observational
Source	Duke University
Contact	Xi Chen, MD
Phone	(919) 684-8434
Email	xi2.chen@duke.edu
Status	Not yet recruiting
Phase
Start date	August 2024
Completion date	August 31, 2027

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05043077` - Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening	Phase 4
Completed	`NCT04838665` - Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study	Phase 4
Completed	`NCT04408807` - Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided	N/A
Recruiting	`NCT03083431` - Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity	Phase 2
Enrolling by invitation	`NCT04985448` - Real World Study of the Effectiveness and Safety of Conbercept Ophthalmic Injection in the Treatment of Retinopathy of Prematurity - Multicenter, Retrospective and Observational Study Based on Real World Data
Recruiting	`NCT02090322` - Bevacizumab 0.500MG Intravitreal There Isn't Lower Than 0.625MG in the Treatment of ROP Type 1	N/A
Completed	`NCT00872664` - Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids	N/A
Unknown status	`NCT00254176` - Cysteine Supplementation in Critically Ill Neonates	Phase 2/Phase 3
Completed	`NCT06452524` - Prematurity and Ophthalmological Changes
Completed	`NCT04101721` - Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity	Phase 3
Enrolling by invitation	`NCT02050971` - Autologous Cord Blood Infusion for the Prevention and Treatment of Prematurity Complications In Preterm Neonates	Phase 1
Terminated	`NCT01335113` - A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
Active, not recruiting	`NCT00027222` - The Early Treatment for Retinopathy of Prematurity Study (ETROP)	Phase 2/Phase 3
Recruiting	`NCT06109285` - Validation of i-ROP DL to Detect More Than Mild ROP	N/A
Completed	`NCT02014454` - Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature	Phase 2
Completed	`NCT01861470` - REDEXAM - Reducing Painful Eye Examinations in Preterm Infants	N/A
Terminated	`NCT00634972` - Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity	Phase 4
Completed	`NCT05701124` - Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity	Phase 3
Completed	`NCT04092127` - Pain of Premature Babies and RetCam (DOLICAM)
Completed	`NCT04621136` - PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity	Phase 1/Phase 2